These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6440155)

  • 61. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
    Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Histydyl-proline diketopiperazine (HPD), a metabolite of thyrotropin-releasing hormone (TRH), improves the ataxic gait in 3-acetylpyridine (3-AP) treated rats].
    Kurahashi K; Kannari K; Kimura K; Matsunaga M; Takebe K
    No To Shinkei; 1986 Sep; 38(9):893-8. PubMed ID: 3790371
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of melatonin and synthetic TRH to determine site of pineal inhibition of TSH secretion.
    Relkin R
    Neuroendocrinology; 1978; 25(5):310-8. PubMed ID: 418360
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of d-amphetamine and morphine on delayed discrimination: signal detection analysis and assessment of response repetition in the performance deficits.
    Koek W; Slangen JL
    Psychopharmacology (Berl); 1984; 83(4):346-50. PubMed ID: 6436863
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The subcellular and organ distribution and natural form of histidyl-proline diketopiperazine in rat brain determined by a specific radioimmunoassay.
    Yanagisawa T; Prasad C; Peterkofsky A
    J Biol Chem; 1980 Nov; 255(21):10290-4. PubMed ID: 7430126
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A new biological contribution of cyclo(His-Pro) to the peripheral inhibition of pancreatic secretion.
    Fragner P; Presset O; Bernad N; Martinez J; Roze C; Aratan-Spire S
    Am J Physiol; 1997 Dec; 273(6):E1127-32. PubMed ID: 9435528
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Histidyl-proline diketopiperazine (His-Pro DKP) immunoreactivity is present in the glucagon-containing cells of the human fetal pancreas.
    Leduque P; Jackson IM; Kervran A; Aratan-Spire S; Czernichow P; Dubois PM
    J Clin Invest; 1987 Mar; 79(3):875-80. PubMed ID: 3102558
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Time-dependent effects of oral thyrotropin-releasing hormone in hyperthyroid female rats.
    Iglesias R; Llobera M; Montoya E
    Horm Metab Res; 1986 Jul; 18(7):454-6. PubMed ID: 3091472
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thyrotropin releasing hormone in the pancreas of newborn rats from streptozotocin-treated mothers.
    Strbák V; Ouafik LH; Resetková E; Oliver C; Giraud P; Dutour A; Salers P; Randusková A
    Life Sci; 1989; 44(12):779-87. PubMed ID: 2495394
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Central thyrotropin-releasing hormone increases hepatic cyclic AMP through vagal-cholinergic and prostaglandin-dependent pathways in rats.
    Yoneda M; Kono T; Watanobe H; Tamano M; Shimada T; Hiraishi H; Nakamura K
    Peptides; 2005 Sep; 26(9):1573-9. PubMed ID: 16112395
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Thyrotropin-releasing hormone (TRH) improves survival in anaphylactic shock: a central effect mediated by the sympatho-adrenomedullary beta-adrenoceptive system.
    Amir S; Harel M; Schachar A
    Brain Res; 1984 Apr; 298(2):219-24. PubMed ID: 6326950
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Thyroliberin (TRH), 6-methyl-5-oxothiomorpholinyl-3-carbonyl histidylproline amide and histidylproline diketopiperazine do not affect the release of [3H]-acetyl choline and [3H]-choline from rat brain tissue cubes.
    Hedley D; Vaughan PF
    Biochem Pharmacol; 1985 Apr; 34(8):1341-3. PubMed ID: 3922374
    [No Abstract]   [Full Text] [Related]  

  • 73. Effects of TRH, cyclo-(His-Pro) and (3-Me-His2)TRH on identified septohippocampal neurons in the rat.
    Lamour Y; Dutar P; Jobert A
    Brain Res; 1985 Apr; 331(2):343-7. PubMed ID: 2859093
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cardiovascular effects of thyrotropin-releasing hormone in normotensive and hypotensive rats: role of rostral ventrolateral medulla.
    Yan J; Chen H; Liao W; Lu S
    Circ Shock; 1992 Jul; 37(3):253-61. PubMed ID: 1423917
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Thyrotropin releasing hormone (TRH): possible physiological functions not related to the neuroendocrine system.
    Horita A; Kalivas PW; Simasko SM
    Rev Pure Appl Pharmacol Sci; 1983; 4(2):111-37. PubMed ID: 6142504
    [No Abstract]   [Full Text] [Related]  

  • 76. The effects of thyrotropin-releasing hormone, metabolites and analogues on locomotor activity in rats.
    Andrews JS; Sahgal A
    Regul Pept; 1983 Oct; 7(2):97-109. PubMed ID: 6658017
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Vasopressin and amphetamine, but not desglycinamide vasopressin, impair positively reinforced visual attention performance in rats.
    Sahgal A
    Behav Brain Res; 1988 Jul; 29(1-2):35-42. PubMed ID: 3401320
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A comparison of different methods of assessing patterns of responding in discrete trial choice procedures.
    Sahgal A; Clincke GH
    Psychopharmacology (Berl); 1985; 87(3):374-7. PubMed ID: 3936094
    [No Abstract]   [Full Text] [Related]  

  • 79. Effects of d-amphetamine, morphine, naloxone, and drug combinations on visual discrimination in rats.
    Andrews JS; Holtzman SG
    Psychopharmacology (Berl); 1988; 94(2):172-7. PubMed ID: 3127842
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effects of thyrotropin releasing hormone on a visual discrimination task in rats.
    Andrews JS; Sahgal A
    Pharmacol Biochem Behav; 1984 Nov; 21(5):715-9. PubMed ID: 6440155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.